Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.

Ligands for natural killer cell receptors: redundancy or specificity.

Cerwenka A, Lanier LL.

Immunol Rev. 2001 Jun;181:158-69. Review.

PMID:
11513137
2.

ULBP1, 2, 3: novel MHC class I-related molecules that bind to human cytomegalovirus glycoprotein UL16, activate NK cells.

Kubin M, Cassiano L, Chalupny J, Chin W, Cosman D, Fanslow W, Müllberg J, Rousseau AM, Ulrich D, Armitage R.

Eur J Immunol. 2001 May;31(5):1428-37.

3.

Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin.

Pende D, Cantoni C, Rivera P, Vitale M, Castriconi R, Marcenaro S, Nanni M, Biassoni R, Bottino C, Moretta A, Moretta L.

Eur J Immunol. 2001 Apr;31(4):1076-86.

4.

A fresh look at tumor immunosurveillance and immunotherapy.

Smyth MJ, Godfrey DI, Trapani JA.

Nat Immunol. 2001 Apr;2(4):293-9. Review.

PMID:
11276199
5.

Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages.

Diefenbach A, Jamieson AM, Liu SD, Shastri N, Raulet DH.

Nat Immunol. 2000 Aug;1(2):119-26.

PMID:
11248803
6.

ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor.

Cosman D, Müllberg J, Sutherland CL, Chin W, Armitage R, Fanslow W, Kubin M, Chalupny NJ.

Immunity. 2001 Feb;14(2):123-33.

7.

Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells.

Groh V, Rhinehart R, Randolph-Habecker J, Topp MS, Riddell SR, Spies T.

Nat Immunol. 2001 Mar;2(3):255-60.

PMID:
11224526
8.

MIC genes: from genetics to biology.

Bahram S.

Adv Immunol. 2000;76:1-60. Review. No abstract available.

PMID:
11079097
9.

Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice.

Cerwenka A, Bakker AB, McClanahan T, Wagner J, Wu J, Phillips JH, Lanier LL.

Immunity. 2000 Jun;12(6):721-7.

10.
11.

NK cell activation: distinct stimulatory pathways counterbalancing inhibitory signals.

Bakker AB, Wu J, Phillips JH, Lanier LL.

Hum Immunol. 2000 Jan;61(1):18-27. Review.

PMID:
10658974
12.

An activating immunoreceptor complex formed by NKG2D and DAP10.

Wu J, Song Y, Bakker AB, Bauer S, Spies T, Lanier LL, Phillips JH.

Science. 1999 Jul 30;285(5428):730-2.

13.

Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA.

Bauer S, Groh V, Wu J, Steinle A, Phillips JH, Lanier LL, Spies T.

Science. 1999 Jul 30;285(5428):727-9.

14.

Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB.

Groh V, Rhinehart R, Secrist H, Bauer S, Grabstein KH, Spies T.

Proc Natl Acad Sci U S A. 1999 Jun 8;96(12):6879-84.

15.

Regulation of immune responses through inhibitory receptors.

Long EO.

Annu Rev Immunol. 1999;17:875-904. Review.

PMID:
10358776
16.

Natural killer cells in antiviral defense: function and regulation by innate cytokines.

Biron CA, Nguyen KB, Pien GC, Cousens LP, Salazar-Mather TP.

Annu Rev Immunol. 1999;17:189-220. Review.

PMID:
10358757
17.
18.

NK cell receptors.

Lanier LL.

Annu Rev Immunol. 1998;16:359-93. Review.

PMID:
9597134
19.

CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4.

Mendiratta SK, Martin WD, Hong S, Boesteanu A, Joyce S, Van Kaer L.

Immunity. 1997 Apr;6(4):469-77.

20.

Arousal and inhibition of human NK cells.

Lanier LL, Corliss B, Phillips JH.

Immunol Rev. 1997 Feb;155:145-54. Review.

PMID:
9059890

Supplemental Content

Support Center